title: Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy.
authors.forename: Ming-Yu
authors.initials: MY
authors.lastname: Lai
authors.forename: Wu-Chang
authors.initials: WC
authors.lastname: Yang
authors.forename: Shon-Dong
authors.initials: SD
authors.lastname: Lee
authors.forename: Yee-Yung
authors.initials: YY
authors.lastname: Ng
mesh_terms: D004351:Drug Resistance; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D009401:Nephrosis / Q000188:drug therapy* / Q000821:virology; D055502:Secondary Prevention; D013997:Time Factors
chemical_list: D019259:Lamivudine